Research Progress on Therapeutic Targeting of Cancer-Associated Fibroblasts to Tackle Treatment-Resistant NSCLC
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Research Progress on Therapeutic Targeting of Cancer-Associated Fibroblasts to Tackle Treatment-Resistant NSCLC
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 15, Issue 11, Pages 1411
Publisher
MDPI AG
Online
2022-11-15
DOI
10.3390/ph15111411
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation
- (2022) Eva Sum et al. Journal for ImmunoTherapy of Cancer
- Fibroblast Activation Protein-Alpha is a Prognostic Biomarker Associated With Ferroptosis in Stomach Adenocarcinoma
- (2022) Zejian Lyu et al. Frontiers in Cell and Developmental Biology
- Ferroptosis: mechanisms, biology and role in disease
- (2021) Xuejun Jiang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased generation of cancer-associated fibroblasts
- (2021) Kaibin Zhu et al. Aging-US
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- p62-Induced Cancer-Associated Fibroblast Activation via the Nrf2-ATF6 Pathway Promotes Lung Tumorigenesis
- (2021) Ji In Kang et al. Cancers
- Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer
- (2021) Haifeng Wang et al. Aging-US
- Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity
- (2021) Eva Sum et al. CLINICAL CANCER RESEARCH
- Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation
- (2021) Pablo Moreno-Ruiz et al. LUNG CANCER
- Artocarpin Targets Focal Adhesion Kinase-Dependent Epithelial to Mesenchymal Transition and Suppresses Migratory-Associated Integrins in Lung Cancer Cells
- (2021) Nongyao Nonpanya et al. Pharmaceutics
- Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis
- (2021) Shichuan Hu et al. Acta Biomaterialia
- Cancer‐associated fibroblasts: Key players in shaping the tumor immune microenvironment
- (2021) Mélanie Desbois et al. IMMUNOLOGICAL REVIEWS
- CXC chemokine ligand‐13 promotes metastasis via CXCR5‐dependent signaling pathway in non‐small cell lung cancer
- (2021) Chia‐Chia Chao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling
- (2021) Yinghui Ren et al. Cell Death & Disease
- Cancer‑associated fibroblast‑derived CCL5 contributes to cisplatin resistance in A549 NSCLC cells partially through upregulation of lncRNA HOTAIR expression
- (2021) Xiangjun Sun et al. Oncology Letters
- Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms
- (2021) Haichuan Hu et al. CANCER CELL
- Matrix stiffness drives stromal autophagy and promotes formation of a protumorigenic niche
- (2021) Anna Hupfer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibroblast Activation Protein‐α Responsive Peptide Assembling Prodrug Nanoparticles for Remodeling the Immunosuppressive Microenvironment and Boosting Cancer Immunotherapy
- (2021) Mengqi Sun et al. Small
- Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects
- (2021) Meggy Suarez-Carmona et al. Journal for ImmunoTherapy of Cancer
- Dipeptidyl Peptidase Inhibition Enhances CD8 T Cell Recruitment and Activates Intrahepatic Inflammasome in a Murine Model of Hepatocellular Carcinoma
- (2021) James M. Henderson et al. Cancers
- The MEK/ERK/miR-21 Signaling Is Critical in Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer Cells
- (2021) Wen-Chien Huang et al. Cancers
- Cross-talk of pyroptosis and tumor immune landscape in lung adenocarcinoma
- (2021) Xin Wang et al. Translational Lung Cancer Research
- VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling
- (2020) Zhuan Zhou et al. CANCER LETTERS
- NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors
- (2020) Kirsty Ford et al. CANCER RESEARCH
- CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
- (2020) Haiyang Zhang et al. Molecular Cancer
- Cancer-associated fibroblasts promote immunosuppression by inducing ROS-generating monocytic MDSCs in lung squamous cell carcinoma
- (2020) Handan Xiang et al. Cancer Immunology Research
- The interplay between slow-cycling, chemoresistant cancer cells and fibroblasts creates a proinflammatory niche for tumor progression
- (2020) Jaebeom Cho et al. CANCER RESEARCH
- Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma
- (2020) Cheong A. Bae et al. Gastric Cancer
- Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer
- (2020) Yann Kieffer et al. Cancer Discovery
- miRNA-26a blocks interleukin-2-mediated migration and proliferation of non-small cell lung cancer cells via vascular cell adhesion molecule-1
- (2020) Lifei Li et al. Translational Cancer Research
- Cancer-associated fibroblasts-derived gamma-glutamyltransferase 5 promotes tumor growth and drug resistance in lung adenocarcinoma
- (2020) Jia-Ru Wei et al. Aging-US
- Autophagy in fibroblasts induced by cigarette smoke extract promotes invasion in lung cancer cells
- (2020) Hsin‐Han Hou et al. INTERNATIONAL JOURNAL OF CANCER
- Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer
- (2020) Marta Trüb et al. Journal for ImmunoTherapy of Cancer
- Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC
- (2020) Aaron C. Tan et al. Journal of Thoracic Oncology
- Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways
- (2020) Alexandra Giatromanolaki et al. LIFE SCIENCES
- Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma
- (2020) Jun Suzuki et al. LUNG CANCER
- Prognostic significance of gamma-glutamyl transferase in patients with metastatic non-small cell lung cancer
- (2019) Yakup Bozkaya et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Cancer-associated fibroblasts contribute to cisplatin resistance via modulating ANXA3 in lung cancer cells
- (2019) Limin Wang et al. CANCER SCIENCE
- Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer‐associated fibroblasts
- (2019) Ahmed E. Hegab et al. JOURNAL OF PATHOLOGY
- FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy
- (2019) Alvaro Quintanal-Villalonga et al. Journal of Thoracic Oncology
- Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
- (2019) In-Hye Ham et al. Molecular Cancer
- LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity
- (2019) Cédric Zeltz et al. Cancers
- Role of Integrins in Resistance to Therapies Targeting Growth Factor Receptors in Cancer
- (2019) Elisabete Cruz da Silva et al. Cancers
- Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer
- (2019) Sana Raoof et al. ONCOGENE
- Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
- (2019) Alessandro Leonetti et al. BRITISH JOURNAL OF CANCER
- PD-L1 Induction by Cancer-Associated Fibroblast-Derived Factors in Lung Adenocarcinoma Cells
- (2019) Inoue et al. Cancers
- The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models
- (2019) David Martínez-García et al. Biomolecules
- Epigenetic SMAD3 repression in tumor-associated fibroblasts impairs fibrosis and response to the antifibrotic drug nintedanib in lung squamous cell carcinoma
- (2019) Rafael Ikemori et al. CANCER RESEARCH
- Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer
- (2019) Koji Teramoto et al. LUNG CANCER
- Single-cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy
- (2019) Claudia X Dominguez et al. Cancer Discovery
- IL6/STAT3 Signaling Orchestrates Premetastatic Niche Formation and Immunosuppressive Traits in Lung
- (2019) Bo Jing et al. CANCER RESEARCH
- Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling
- (2018) Yanmei Yi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9
- (2018) Weiling He et al. BMC CANCER
- LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
- (2018) James W. Purcell et al. CANCER RESEARCH
- Reverse of non-small cell lung cancer drug resistance induced by cancer-associated fibroblasts via a paracrine pathway
- (2018) Quanhui Zhang et al. CANCER SCIENCE
- Hesperidin suppresses the migration and invasion of non-small cell lung cancer cells by inhibiting the SDF-1/CXCR-4 pathway
- (2018) Rongmu Xia et al. LIFE SCIENCES
- The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)
- (2018) Brandon Golding et al. Molecular Cancer
- Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer
- (2018) Thomas Karsten Kilvaer et al. PLoS One
- Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma
- (2018) Yusheng Cheng et al. Cell Death & Disease
- Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma
- (2018) Takashi Sakai et al. LUNG CANCER
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Podoplanin expression in cancer-associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung adenocarcinoma
- (2017) Yasuaki Kubouchi et al. HISTOPATHOLOGY
- A Human Antibody That Binds to the Sixth Ig-Like Domain of VCAM-1 Blocks Lung Cancer Cell Migration In Vitro
- (2017) Mi Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4
- (2017) Christopher J Hanley et al. JNCI-Journal of the National Cancer Institute
- Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung Cancer
- (2017) Kazuhiko Shien et al. MOLECULAR CANCER THERAPEUTICS
- Silencing of TGF-β1 in tumor cells impacts MMP-9 in tumor microenvironment
- (2017) Lakisha D. Moore-Smith et al. Scientific Reports
- Gas6 derived from cancer-associated fibroblasts promotes migration of Axl-expressing lung cancer cells during chemotherapy
- (2017) Ryu Kanzaki et al. Scientific Reports
- Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4
- (2017) Christopher J Hanley et al. JNCI-Journal of the National Cancer Institute
- Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade
- (2017) Dirk Zboralski et al. Cancer Immunology Research
- Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells
- (2017) Dongya Zhang et al. Scientific Reports
- The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts
- (2016) Melanie Mediavilla-Varela et al. BMC CANCER
- Clinicopathological significance of caveolin-1 expression by cancer-associated fibroblasts in lung adenocarcinoma
- (2016) Kei Shimizu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
- (2016) Mark M. Awad et al. JOURNAL OF CLINICAL ONCOLOGY
- IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling
- (2016) Yasushi Shintani et al. Journal of Thoracic Oncology
- RG7386, a Novel Tetravalent FAP-DR5 Antibody, Effectively Triggers FAP-Dependent, Avidity-Driven DR5 Hyperclustering and Tumor Cell Apoptosis
- (2016) P. Bru nker et al. MOLECULAR CANCER THERAPEUTICS
- Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway
- (2016) Leilei Tao et al. Scientific Reports
- The BCL-2 protein family, BH3-mimetics and cancer therapy
- (2015) A R D Delbridge et al. CELL DEATH AND DIFFERENTIATION
- Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients
- (2015) Erin M. Bertino et al. Clinical Lung Cancer
- Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer
- (2015) R Navab et al. ONCOGENE
- URGCP promotes non-small cell lung cancer invasiveness by activating the NF-κB-MMP-9 pathway
- (2015) Junchao Cai et al. Oncotarget
- IL-24 Inhibits Lung Cancer Cell Migration and Invasion by Disrupting The SDF-1/CXCR4 Signaling Axis
- (2015) Janani Panneerselvam et al. PLoS One
- Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers
- (2015) Thomas K. Kilvaer et al. PLoS One
- Senescent cancer-associated fibroblasts secrete active MMP-2 that promotes keratinocyte dis-cohesion and invasion
- (2014) Y Hassona et al. BRITISH JOURNAL OF CANCER
- Podoplanin-Positive Cancer-Associated Fibroblasts in the Tumor Microenvironment Induce Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma with EGFR Mutation
- (2014) Tatsuya Yoshida et al. CLINICAL CANCER RESEARCH
- Presence of podoplanin-positive cancer-associated fibroblasts in surgically resected primary lung adenocarcinoma predicts a shorter progression-free survival period in patients with recurrences who received platinum-based chemotherapy
- (2014) Haruki Koriyama et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer
- (2014) Lanxi Song et al. Journal of Thoracic Oncology
- Matrix Stiffening and β 1 Integrin Drive Subtype-Specific Fibroblast Accumulation in Lung Cancer
- (2014) Marta Puig et al. MOLECULAR CANCER RESEARCH
- Matrix Metalloproteinase (MMP)-9 in Cancer-Associated Fibroblasts (CAFs) Is Suppressed by Omega-3 Polyunsaturated Fatty Acids In Vitro and In Vivo
- (2014) Ayumi Taguchi et al. PLoS One
- Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy
- (2014) Elizabeth J. Hamson et al. Proteomics Clinical Applications
- Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma
- (2013) Massimiliano Cadamuro et al. HEPATOLOGY
- Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia
- (2013) Eric Tran et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Activation of the FGF2-FGFR1 Autocrine Pathway: A Novel Mechanism of Acquired Resistance to Gefitinib in NSCLC
- (2013) Hideki Terai et al. MOLECULAR CANCER RESEARCH
- Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
- (2013) Sunitha Kakarla et al. MOLECULAR THERAPY
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recruitment of Podoplanin Positive Cancer-Associated Fibroblasts in Metastatic Lymph Nodes Predicts Poor Prognosis in Pathological N2 Stage III Lung Adenocarcinoma
- (2012) Shinya Neri et al. ANNALS OF SURGICAL ONCOLOGY
- Cross-Species Functional Analysis of Cancer-Associated Fibroblasts Identifies a Critical Role for CLCF1 and IL-6 in Non-Small Cell Lung Cancer In Vivo
- (2012) S. Vicent et al. CANCER RESEARCH
- An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
- (2012) L. A. Byers et al. CLINICAL CANCER RESEARCH
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
- (2012) Julian R. Molina et al. MAYO CLINIC PROCEEDINGS
- Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
- (2012) Zhenfeng Zhang et al. NATURE GENETICS
- Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis
- (2011) Jacky G. Goetz et al. CELL
- The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs
- (2011) Robert R. Langley et al. INTERNATIONAL JOURNAL OF CANCER
- Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: Role in non–small cell lung cancer tumor proliferation
- (2011) Ori Wald et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Cancer-Associated Fibroblasts Derived from EGFR-TKI-Resistant Tumors Reverse EGFR Pathway Inhibition by EGFR-TKIs
- (2010) S. R. Mink et al. MOLECULAR CANCER RESEARCH
- Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
- (2009) W. Wang et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Talabostat and Docetaxel in Advanced Non-small Cell Lung Cancer
- (2009) R.M. Eager et al. CLINICAL ONCOLOGY
- Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
- (2009) C. Gjerdrum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started